Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > John Kennedy Senior vs Mr mugsy Janitor style of investing.

<< Previous

Bullboard Posts

Next >>

Comment by wofatson Mar 20, 2022 6:45pm

117 Views

Post# 34530053

RE:John Kennedy Senior vs Mr mugsy Janitor style of investing.

Funny you should mention that .

I was just noticing how the short positions had increased the end of December

The stock closed at $5.30 on that date. Odd.

$GUD.TO	KNIGHT THERAPEUTICS INC.	4,754,768	71,271	27 Feb 2022
$GUD.TO	KNIGHT THERAPEUTICS INC.	4,683,497	-37,952	14 Feb 2022
$GUD.TO	KNIGHT THERAPEUTICS INC.	4,721,449	-73,403	30 Jan 2022
$GUD.TO	KNIGHT THERAPEUTICS INC.	4,794,852	-48,500	14 Jan 2022
$GUD.TO	KNIGHT THERAPEUTICS INC.	4,843,352	1,981,686	30 Dec 2021
$GUD.TO	KNIGHT THERAPEUTICS INC.	2,861,666	69,267	14 Dec 2021